EQUIFINE

Description

Is indicated for the treatment of internal and external parasitisms susceptible to the active principle.

Guaranteed composition:

Each 100 g of oral gel contains:

• Ivermectin 1,87 g
• Excipients q.s. 100 g

Species for which it is recommended:

Equines.

Route of administration:

Via Oral exclusively.

The product in dosing syringe is designed to facilitate its application without causing discomfort to the animal, nor efforts for those who administer the product. Place the dose on the back and above the tongue, lifting the horse’s head for a few seconds while the product passes or swallows.

Dosage:

Administer 200 μg of Ivermectin per kilogram of live weight. In practice, the 6.42g syringe is used to treat an equine of 600 kg or half of the syringe for an equine of 300 kg. The plunger of the syringe has 6 marks and each mark reaches to treat 100Kg of weight.

Withdrawal time:

The treated animals should not be slaughtered for human consumption until 14 days after the end of the treatment.

Cautions:

• Do not treat mares in gestation.
• For better environmental safety, it is recommended that containers be disposed of by incinerating or burying them and not allowing waste to contaminate rivers or water sources.

Contraindications:

• None known.
• Individual hypersensitivity to the components of the product.
• Keep in a cool, dry place protected from light.

Presentations:

Plastic dosing syringe x 6,42 g.

ICA Reg. No.: 7935-MV